HUM Humana Inc
Company Analysis
Latest News
Value Investor Richard Pzena Trims Humana Stake by 17%
Deep-value investor Richard Pzena of Pzena Investment Management has reduced his firm's position in health insurer Humana (HUM) by 17.12%, according to a...
Humana Forms New Joint Venture with BlackRock for CenterWell Primary Care Clinics
Humana announced it is entering into a new joint venture with funds managed by BlackRock to manage and operate its network of CenterWell Senior Primary Care...
Pzena Trims Humana (HUM) Stake After Stock Value Surges
Value investing firm Pzena Investment Management reduced its holding in health insurer Humana by 19.5% during the second quarter of 2026. According to a...
Stanley Druckenmiller's Duquesne Exits Humana (HUM) Amid Sector Rotation
In a significant portfolio shift, Stanley Druckenmiller's Duquesne Family Office completely sold its stake in health insurer Humana (HUM), liquidating 137,500...
Humana beats second quarter 2026 EPS estimates on strong revenue, though the medical benefit ratio rises.
Humana reported second quarter 2026 revenue of $40.87 billion and adjusted EPS of $7.61, exceeding analyst expectations. The results were driven by significant...
Humana Inc Q2 2026 Earnings Preview: What Analysts Expect on July 29, 2026
Analysts anticipate Humana will report Q2 2026 revenue of approximately $30.85 billion and EPS of $6.22, with the current stock price of $342.15 trailing the...
Humana's first quarter 2026 revenue of $39.6B slightly beat estimates while EPS missed, but the company affirmed its full-year adjusted EPS guidance.
Humana reported first quarter 2026 revenue of $39.6 billion, up from $32.1 billion a year prior, while GAAP EPS of $9.83 missed consensus estimates and...
Humana Inc Q1 2026 Earnings Preview: What Analysts Expect on April 29, 2026
Consensus estimates for Humana's Q1 2026 stand at $39.5 billion in revenue (+22.8% YoY) and $9.97 in EPS (-13.9% YoY), with the stock trading near $215.23...